Short communication: No evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infection

AIDS Research and Human Retroviruses

Volumn 26, Issue 11, 2010, Pages 1229-1231

  Perzova, Raisa ^a   Benz, Patricia ^a   Abbott, Lynn ^a   Welch, Caitlin ^a   Thomas, Anish ^a   Ghoul, Rawad El ^a   Sanghi, Swathi ^a   Nara, Peter ^b   Glaser, Jordon ^c   Siegal, Frederick P ^d   Dosik, Harvey ^e   Poiesz, Bernard J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Biological Mimetics Inc   (United States)

^c STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^d ST VINCENT S HOSPITAL   (United States)

^e NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ARTICLE; BLOOD DONOR; CANCER PATIENT; CHIMPANZEE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 4; HUMAN T CELL LEUKEMIA VIRUS 4 INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; RETROVIRUS INFECTION; SPINAL CORD DISEASE; UNITED STATES;

ADOLESCENT; ADULT; AGED; DELTARETROVIRUS; DELTARETROVIRUS INFECTIONS; DNA, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 3; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; NEW YORK; POLYMERASE CHAIN REACTION; PREVALENCE; VIROLOGY; YOUNG ADULT;

EID: 78649295913     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0079     Document Type: Article

References (19)

1. Thomas A, Perzova R, Abbott L, et al.: LGL leukemia and HTLV. AIDS Res Hum Retroviruses 2010;26:1-8.
2. Sintasath DM, Wolfe ND, Lebreton M, et al.: Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon. Emerg Infect Dis 2009;15:175-184.
3. Sintasath DM, Wolfe ND, Zheng HQ, et al.: Genetic characterization of the complete genome of a highly divergent simian T lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey. Retrovirology 2009;6:97.
4. Poiesz BJ, Poiesz MJ, Choi D: The human T-cell lymphoma/leukemia viruses. Cancer Invest 2003:253-277.
5. Takemura T, Yamashita M, Shimada MK, et al.: High prevalence of simian T-lymphotropic virus type L in wild Ethiopian baboons. J Virol 2002;76:1642-1648.
6. Meertens L and Gessain A: Divergent simian T-cell lymphotropic virus type 3 (STLV-3) in wild-caught Papio hamadryas papio from Senegal: Widespread distribution of STLV-3 in Africa. J Virol 2003;77:782-789.
7. Liégeois F, Lafay B, Switzer WM, et al.: Identification and molecular characterization of new STLV-1 and STLV-3 strains in wild-caught nonhuman primates in Cameroon. Virology 2008;371:405-417.
8. Calattini S, Chevalier SA, Duprez R, et al.: Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2005;2:30.
9. Wolfe ND, Heneine W, Carr JK, et al.: Emergence of unique primate Tlymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA 2005;102:7994-7999.
10. Calattini S, Betsem E, Bassot S, et al.: New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results. J Infect Dis 2009;199:561-564.
11. Burmeister T, Schwartz S, Hummel M, Hoelzer D, and Thiel E: No genetic evidence for involvement of delta retroviruses in adult patients with precursor and mature T-cell neoplasms. Retrovirology 2007;4:11.
12. Duong YT, Jia H, Lust JA, et al.: Absence of evidence of HTLV-3 and HTLV-4 in patients with large granular lymphocyte (LGL) leukemia. AIDS Res Hum Retro 2008;24:1503-1505.
13. Calattini S, Chevalier SA, Duprez R, et al.: Human T-cell lymphotropic virus type 3: Complete nucleotide sequence and characterization of the human tax3 protein. J Virol 2006;80:9876-9888.
14. Switzer WM, Qari SH, Wolfe ND, et al.: Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J Virol 2006;80:7427-7438.
15. Anderson DW, Epstein JS, Pierik LT, et al.: Development of the public health service of criteria for serological confirmation of HTLV-I/II infections. In Human Retrovirology (Blattner W, ed.), New York: Raven Press, 1990; pp 391-396.
16. Ehrlich GD, Glaser JB, LaVigne K, et al.: Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: Type-specific identification of HTLVs by polymerase chain reaction. Blood 1989;74:1658-1664.
17. Macon WR, Lo SC, Poiesz BJ, et al.: Acquired immunodeficiency syndrome-like illness associated with systemic Mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man. Hum Pathol 1993;24:554-558.
18. Mahieux R and Gessain A: The human HTLV-3 and HTLV-4 retroviruses: New members of the HTLV family. Path Biol 2009;57:161-166.
19. Switzer WM, Salemi M, Qari SH, et al.: Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology 2009;6:9.